DIR Return Create A Forum - Home
---------------------------------------------------------
MS Speaks
HTML https://msspeaks.createaforum.com
---------------------------------------------------------
*****************************************************
DIR Return to: TREATMENTS
*****************************************************
#Post#: 41--------------------------------------------------
DRUG INFORMATION
By: agate Date: December 2, 2013, 9:42 pm
---------------------------------------------------------
Information about prescription and over-the-counter medicine is
available at Medline Plus
HTML http://www.nlm.nih.gov/medlineplus/druginformation.html.
#Post#: 2298--------------------------------------------------
Promising MS agents in late-stage development
By: agate Date: December 6, 2018, 12:48 pm
---------------------------------------------------------
This provides a fairly clear brief summary of the currently
available MS drugs and the drugs in the pipeline.
Interesting that there are now several drugs for SPMS listed in
the pipeline. One of them, masitinib AB is designated for
"rfSPMS" (relapse-free secondary progressive MS).
From P&T Community (received December 6, 2018):
HTML https://www.ptcommunity.com/journal/article/full/2018/12/750/promising-multiple-sclerosis-agents-late-stage-development
#Post#: 2812--------------------------------------------------
The MS disease-modifying medications (National MS Society bookle
t)
By: agate Date: February 13, 2020, 10:03 am
---------------------------------------------------------
This .pdf file is a National MS Society booklet about the MS
drugs and seems quite comprehensive coverage of an increasingly
complex topic:
HTML https://www.nationalmssociety.org/NationalMSSociety/media/MSNationalFiles/Brochures/Brochure-The-MS-Disease-Modifying-Medications.pdf
#Post#: 3525--------------------------------------------------
AB Science OK'd to start masitinib Phase 3 trial in progressive
MS
By: agate Date: January 12, 2022, 11:21 pm
---------------------------------------------------------
From Multiple Sclerosis News Today (January 5, 2022)--"AB
Science OK'd to Start Masitinib Phase 3 Trial in Progressive
MS":
HTML https://bit.ly/3zStuqf
*****************************************************